A potential monosaccharidic mimetic of the sialyl Lewis X tetrasaccharide (sLe X ) was identified based on an in silico docking study using the crystal structure of an E-selectin-sLe X complex.
Introduction
Oligosaccharides are known to play an important role in cell recognition processes and in the communication between cells in higher organisms.
1 A prominent example is the recruitment of leucocytes during the inflammatory cascade, which is initiated by the interaction between selectins and their cognate oligosaccharide ligands such as sialyl Lewis X (sLe X , 1) ( Fig.1 ). Undesired interactions caused by overexpression or dysregulation have been associated with various diseases e.g. asthma, 3 psoriasis, 4 reperfusion syndrome 1b or the metastasis of tumors.
Previous studies have shown that the three hydroxyl groups of the L-fucose 8 and the carboxylic acid moiety of the sialic acid 9 are essential for binding of sialyl Lewis X (1) towards the selectins. However, the L-fucose portion has been successfully substituted by other monosaccharides with similar configuration such as D-arabinose, 6a ,6b L-galactose 7e,10 or Dmannose as demonstrated by Kogan's functional mannosyl mimetic 2. 7b,7c Furthermore, the (S)-cyclohexyl lactic acid moiety successfully employed by Ernst and Thoma e.g. in compound 3 turned out to be a privileged mimetic for the sialic acid portion. 7d,11 A potential general drawback of oligosaccharidic therapeutics is their instability against acidic hydrolysis and their degradation by glycosidases. For instance, O-fucosidic bonds are typical targets for ubiquitous fucosidases. 12 An approach to overcome the metabolic lability of O-glycosidic bonds can be the use of Cglycosidic mimetics, 7c,10 the synthesis of which can be effected along various routes. 13 Here, we report on the preparation and biological evaluation of potential sLe X analogues based on a mannosylated 2,7-dihydroxynaphthalene scaffold.
Results and Discussion
Virtual docking experiments using the crystal structure of the E-selectin/sLe X complex and mimetics composed of various aromatic and heteroaromatic core structures in combination with (S)-cyclohexyl lactic acid and D-mannose revealed a good fit of compound 4 containing an -Cmannosylated 2,7-dihydroxynaphthalene ( Figure 1, Figure 2 ). The direct glycosylation of 9 to the acceptor 7 in the presence of TMSOTf gave the C-glycoside 10 in 61% yield but unfortunately with the undesired β-configuration at the anomeric center. 18 Hydrolysis of the methyl ester and cleavage of the benzyl ethers gave the corresponding -configured mimetic 12 in 65% yield (Scheme 2).
Scheme 2. Synthesis of -C-mannoside 12 and α-C-mannoside 4. Reagents and conditions: a) All-OH, AcCl; b) NaH, BnBr, DMF, 0 °C; c) (Ph 3 P) 3 It has been demonstrated with other phenolic acceptors that α-C-mannosides can be obtained if ZnCl 2 is used as the promoter. 18 However, these conditions only gave a 2:1 mixture of the α-Cglycoside 13C and the α-O-glycoside 13O. The products could be separated after ester hydrolysis giving the acid 14C in 25% over two steps. Unfortunately, the mannosyl residue in 14C was found to adopt the 1 C 4 conformation 18 which also prevailed after hydrogenolysis of the benzyl ethers to yield the α-configured mimetic 4, albeit in an unfavorable conformation (Scheme 2). For comparison of its biological activity with the two C-mannosides, glycoside 17 was synthesized from the acetylated mannosyl trichloroacetimidate 15 which has a strong preference for -O-glycosylation. Donor 15 was obtained from D-mannose in three steps 19 and reacted with phenol 7 in the presence of TMSOTf to give the -configured O-glycoside 16 in 70% yield. After removal of the acetyl groups and alkaline hydrolysis of the methyl ester, the O-glycosidic mimetic 17 was obtained in 61% yield (Scheme 3). As expected, the mannose in this compound adopts the 4 C 1 conformation while the distance between carboxylate and the carbohydrate is larger than in the C-glycosides 4 and 12.
The three mimetics 4, 12 and 17 were evaluated for their selectin inhibition in a cell-based assay, based on binding of soluble P-or E-selectin-Immunoglobulin chimera to selectin ligandbearing murine Th1 cells or neutrophils. However, no inhibition exceeding 50% could be observed up to concentrations of 1 mM.
Assuming that the mannosyl residue in 4 adopts a 1 C 4 conformation in solution we performed docking calculations in order to test whether 4 could fit favorably into the binding pocket of E-selectin in this conformation. None of the 100 best poses showed a twofold coordination of the calcium and the binding energy score was lower than for 4 with the mannosyl residue in a 4 C 1 conformation. This result might explain why the compound did not show the expected inhibition in the biological test. DFT calculations (B3LYP/SOLV, 6-31G**) predict the 4 C 1 conformer of a simplified model of 4 to be 1.7 kJ•mol -1 more stable in the gas phase while the 1 C 4 conformer is more stable in solution by 11.5 kJ•mol -1 , see supporting information.
Conclusions
Three potential monosaccharidic mimetics of the sialyl Lewis X tetrasaccharide based on 2,7-dihydroxynaphthalene have been prepared and evaluated for their selectin-inhibitory activity. While mimetic 4 compared favorably with other tested mimetics in an in silico screening, none of the compounds showed a significant biological activity in a cytometric assay up to concentrations of 1 mM. The reason for this may be the unexpected preference of the mannosyl residue in 4 for the 1 C 4 conformation, in which the spatial arrangement of the hydroxyl groups in positions 2, 3, and 4 precludes the required binding of the Ca 2+ -ion in E-selectin.
Experimental Section
General. Moisture sensitive reactions were carried out under argon atmosphere in dried glassware sealed by rubber septa. Unless otherwise specified, chemicals were obtained from commercial suppliers and were used without further purification. CH 2 Cl 2 and acetonitrile were dried over CaH 2 and distilled under argon atmosphere prior to use. ZnCl 2 was dried at 130 °C in vacuo. Flash chromatography was performed on silica gel 60 (0.035-0.070 mm, Acros). Chromatography solvents (cyclohexane, EtOAc) were distilled prior to use. For analytical TLC, Merck silica gel aluminium sheets (60 F 254 ) were used. Visualisation was accomplished by UV (254 nm) and sugar reagent 20 (1 M ethanolic H 2 SO 4 /0.2% ethanolic 3-methoxyphenol solution 1:1). Purification of products was accomplished by flash chromatography on silica gel and the purified compounds showed a single spot in analytical TLC. 1 H and 13 C NMR spectra were recorded on a Bruker AC 300, AV 400 or DRX 500 in CDCl 3 or methanol-d 4 using the residual solvent peak as internal reference (CDCl 3, δ H = 7.26, δ C = 77.16, methanol-d 4 , δ H = 3.31, δ C = 49.0). Optical rotations were measured at room temperature on a Krüss P8000 polarimeter at 589 nm or on a Perkin Elmer 241 polarimeter at 546 and 578 nm; the optical rotation at 589 nm was extrapolated using the Drude equation. IR spectra were recorded on a ThermoNicolet Avatar 370 FT-IR spectrometer. FAB mass spectrometry was carried out on with VG70S (Xe-FAB ionisation) with m-nitrobenzyl alcohol as the matrix. For exact mass determination (FAB-HRMS), PEG 300 or PEG 600 was used as internal standard. ESI mass spectrometry was carried out on an Agilent 1200 LC/MSD Trap XCT. The samples were dissolved in acetonitrile (c ≈ 0.1 g/l) and injected via an Agilent 1200 HPLC with an Ascentis Express C8 (30 x 2.1 mm, 2.7 µm particle size) column (acetonitrile/water 80:20, Flow: 0.5 ml/min). Exact mass determination (ESI-HRMS) was carried out on a Q-ToF-Ultima 3-Instrument with a Lock Spray-interface. NaI/CsI clusters were used as an external reference.
Docking
The program Glide 4.5 21 was used for the docking of a small, manually designed, library of potential sLe X mimetics. The setup of the receptor was performed using the protein preparation wizard of the Maestro program 22 based on the X-ray structure of E-selectin complexed with sLe X (pdb code 1G1T). 23 The ligands were built and optimized using Maestro. The grid defining the binding site was positioned using the sLe X ligand as center and had a dimension of 31 Å x 29 Å x 29 Å. The docking was performed in GlideScore SP4.5 mode using default parameters. The 10 best poses were stored for each ligand and manually inspected.
Cellular assay for determination of inhibitory potency for E-and P-selectin
Inhibition of binding of E-and P-selectin to its natural ligands on either T cells or neutrophils was tested by cytometry as described. 24 In short, CD4+ T cells were isolated from mice, activated under Th1 conditions and incubated with soluble E-or P-selectin-IgG chimera in absence or presence of the compounds. Cell-bound selectin was stained with fluorescently labeled anti-human IgG antibody as secondary reagent in HBSS containing Ca 2+ and Mg 2+ and quantified in a fluorescence-activated cell sorter (FACS). Alternatively, neutrophils were stained in whole blood after erythrocyte lysis as above and identified by anti GR-1 antibody.
(S)-3-Cyclohexyl-2-(7-hydroxynaphthalen-2-yloxy)-propionic acid methyl ester (7) A solution of 6 (1.68 g, 5.28 mmol) in dry acetonitrile (8 mL) was added to a mixture of 2,7-dihydroxynaphthalene ( 32.8, 26.7, 26.5, 26.3 (CH 2 
(2S)-3-Cyclohexyl-2-[2-hydroxy-1-(2,3,4,6-tetra-O-benzyl--D-mannopyranosyl) naphthalen-7-yloxy]propionic acid (11)
Methyl ester 10 (327 mg, 0.39 mmol) was stirred in a mixture of 1,4-dioxane (10 mL), methanol (3.5 mL) and 4 N NaOH (1 mL) for 3 h at room temperature. The reaction was quenched by adding 2 N HCl (10 mL) and H 2 O (30 mL) and the mixture was extracted with EtOAc (2 x 20 mL). The combined organic phases were dried over Na 2 SO 4 and the solvent was removed in vacuo. The crude residue was purified by flash chromatography (cyclohexane/ 128.9, 128.8, 128.7, 128.5, 128.4, 128.1, 128.0, 127.9, 127.8, 127.5, (CH Ph) , 124.7 (C-4a), 118.7 (C-3), 114.6 (C-6), 111.3 (C-1), 102.3 (C-8), 84.1 (C-3'), 80.2 (C-5'), 79.5 (C-1'), 75.8, 75.6, 75.1 (CHCOOH, C-2', CH 2 Ph), 74.9 (CH 2 Ph), 74.8 (C-4'), 73.8 (CH 2 Ph), 72.2 (CH 2 Ph), 68.9 (C-6'), 40.3 (CH 2 CHCOOH), 34.3, 34.0, 32.8, 27.3, 26.5, 26.4 (CH, 5 CH 2 .9 (C-7), 157.8 (C-2), 135.1 (C-8a), 132.1 (C-5), 131.2 (C-4), 126.6 (C-4a), 118.9 (C-3), 117.1 (C-6), 114.4 (C-1), 104.9 (C-8), 84.1 (C-5'), 81.3 (C-1'), 77.5 (CHCOOH), 77.0 (C-3'), 74.1 (C-2'), 69.2 (C-4'), 63.6 (C-6'), 42.4 (CH 2 CHCOOH), 36.7, 35.9, 34.6, 28.4, 28.3, 28.1 (CH, 5 CH 2 A mixture of 9 (320 mg, 0.50 mmol), 7 (174 mg, 0.53 mmol) and molecular sieves 4 Å (1.00 g) in dry CH 2 Cl 2 (10 mL) was stirred at room temperature for 20 min under argon atmosphere to remove traces of water from the reactants. Dried ZnCl 2 (206 mg, 1.52 mmol) was added and the mixture was stirred for 2 h at room temperature. The reaction was quenched by addition of saturated aq NaHCO 3 (20 mL) and extracted with CH 2 Cl 2 (3 x 10 mL). The combined organic phases were dried over Na 2 SO 4 and the solvent was removed in vacuo. The mixture (2:1) of 13C and 13O (150 mg total, 0.18 mmol) was dissolved in a mixture of 1,4-dioxane (5 mL), methanol (1.8 mL) and 4 N aq NaOH (0.5 mL) and stirred for 3 h at room temperature. The reaction was quenched with 2 N HCl (10 mL) and H 2 O (30 mL). The mixture was extracted with EtOAc (3 x 20 mL). The combined organic phases were dried over Na 2 SO 4 and the solvent was removed in vacuo. The crude residue was purified by flash chromatography (cyclohexane/EtOAc 3:1) to give 14C and 14O (combined yield 138 mg, 0.16 mmol, 93%). The separation yielded a mixture of 14C and 14O (29 mg, 34 µmol, 19%) (C-2, C-7) , 138.7, 138.4, 138 .0 (4 C-1'''), 134.6 (C-8a), 130. 4, 128.9, 128.7, 128.2, 128.1, 128.0, 127.9, 127.8, 127.6 (20 CH Ph) , 124.9 (C-4a), 118.0 (C-3), 115.2 (C-6), 114.4 (C-1), 105.2 (C-8), 76.3 (C-5'), 75.8 (C-2'), 75.1 (C-4'), 74.6 (CHCOOH), 74.2 (C-3'), 73.6, 73.3, 73.1, 71 .9 (CH 2 Ph), 68.3 (C-1'), 67.3 (C-6'), 40.1 (CH 2 CHCOOH), 33.9 (CH, CH 2 ), 32. 5, 26.6, 26.4, 26.3 (CH 2 128.8, 128.7, 128.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8 (20 CH Ph) , 125.9 (C-4a), 117.1 (C-6, C-3), 110.4 (C-1), 107.9 (C-8), 96.6 (C-1'), 80.3 (C-3'), 75.5 (CH 2 Ph), 75.0 (C-4'), 74.9 (C-2'), 74.6 (CHCOOH), 73.5, 73.1 (CH 2 Ph), 72.8 (C-5'), 72.7 (CH 2 Ph), 69.1 (C-6'), 40.4 (CH 2 CHCOOH), 34.3 (CH), 34.0, 32.7, 26.7, 26.5, 26.3 (CH 2 
(2S)-3-Cyclohexyl-2-[2-hydroxy-1-( -D-mannopyranosyl)naphthalen-7-yloxy]propionic acid (4)
A mixture of 14C (52 mg, 62 µmol) and Pd(OH) 2 on charcoal (4 mg, 20 wt% Pd) in MeOH (2 mL) was degassed in an autoclave under N 2 and then flushed with H 2 (10 bar). The mixture was stirred under H 2 (10 bar) at room temperature. The catalyst was removed by filtration through Celite and the solvent was removed in vacuo. The crude residue was purified by flash chromatography (EtOAc/EtOH 9:1) to give 4 (18 mg, 38 µmol, 61%) as a colorless oil. [α] 25 D = +16.9 (c = 0.16, MeOH), R f = 0.11 (EtOAc/EtOH 9:1). IR (ATR, max , cm -1 ): 3339, 2921, 2850, 1726, 1624, 1522, 1450, 1226, 1137, 1073, 833, 783 . 1 H NMR (400 MHz, CD 3 OD): δ H 7.65 (m c , C NMR, HSQC (100.6 MHz, CD 3 OD) δ C 178.9 (COOH), 158.4 (C-7), 156.8 (C-2), 136.9 (C8a), 131.4, 131.3 (C-4, C-5) , 126.8 (C-4a), 118.0 (C-3), 117.1 (C-1), 116.9 (C-6), 107.3 (C-8), 82.0 (C-5'), 77.3 (CHCOOH), 72.9 (C-3') 71.3 (C-4'), 70.6 (C-1'), 69.2 (C-2'), 61.5 (C-6'), 42.2 (CH 2 CHCOOH), 36.0, 35.5, 34.4, 31.2, 27.9, 27.8 (CH, 5 CH 2 , 2851, 1749, 1631, 1514, 1437, 1370, 1208, 1129 1036, 835, 755 . 1 H
